申请人:CONSTELLATION PHARMACEUTICALS INC
公开号:WO2019161162A1
公开(公告)日:2019-08-22
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT).
提供的是Formula (I)的化合物及其药用可接受的盐和组合物,可用于治疗与组蛋白乙酰转移酶(HAT)相关的各种疾病。